Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$133,178,566
+$64,576,970 QoQ
Shares Held
524,387
+86.8% QoQ
Ownership
0.022%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#260
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Epoch Investment Partners, Inc. holds $994,368,960 across 9 Drug Manufacturers - General names. JNJ ranks #4 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
1,376,588 | $346,404,603 | |
| 2 | LLY |
ELI LILLY & Co
|
119,698 | $143,569,383 | |
| 3 | MRK |
Merck & Co., Inc.
|
1,050,056 | $134,932,195 | |
| 4 | JNJ |
Johnson & Johnson
This page
|
524,387 | $133,178,566 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,141,710 | $65,785,328 | |
| 6 | PFE |
Pfizer Inc
|
2,723,573 | $65,583,636 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
485,736 | $61,367,885 | |
| 8 | AZN |
Astrazeneca PLC
|
157,316 | $29,830,259 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,178,566 | 524,387 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $68,601,596 | 280,648 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $87,346,143 | 422,064 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $87,013,711 | 469,279 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $75,362,725 | 493,373 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $78,200,689 | 471,543 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $68,966,384 | 476,880 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $92,228,830 | 569,103 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $84,083,799 | 575,286 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $89,164,741 | 563,656 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $96,776,289 | 617,432 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $133,562,166 | 857,542 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $146,898,501 | 887,497 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $135,929,885 | 876,967 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $148,408,786 | 840,129 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $140,643,974 | 860,945 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $155,350,004 | 875,162 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $165,054,474 | 931,301 | Shares | Other | 2022-05-13 | |
| 2021-12-31 | $142,435,276 | 832,614 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $141,410,853 | 875,609 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $142,251,012 | 863,488 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $170,987,274 | 1,040,385 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $160,616,204 | 1,020,563 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $168,337,722 | 1,130,694 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $166,034,809 | 1,180,650 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $165,535,363 | 1,262,376 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||